Philips wins big French RIS contract
Philips Medical Systems of Best, the Netherlands, has announcedthe receipt of a major contract to provide 40 of its Rados radiologyinformation systems to a large PACS installation in France. TheRados systems will be used to connect 50 hospitals in the
Philips Medical Systems of Best, the Netherlands, has announcedthe receipt of a major contract to provide 40 of its Rados radiologyinformation systems to a large PACS installation in France. TheRados systems will be used to connect 50 hospitals in the Paris-basedAssistance Publique-Hpitaux de Paris (AP-HP).
The installation is part of AP-HP's ambitious MIRIAM project,which is designed to centralize hospitals in the group arounda single RIS and PACS. AP-HP is the largest hospital group inEurope, comprising 30,000 patient beds, an annual budget of about$6 billion, and 57 medical imaging departments.
Philips will install Rados at two pilot facilities, and then deploya total of 40 systems in four phases over the next four to fiveyears, beginning in September 1997.
On the PACS side, Agfa was named to provide its Impax networkingsystem to AP-HP.
ASCO: Study Reveals Significant Racial/Ethnic Disparities with PSMA PET Use for Patients with mPCa
May 30th 2025Latinx patients with metastatic prostate cancer were 63 percent less likely than non-Hispanic White patients to have PSMA PET scans, according to a study of 550 patients presented at the American Society of Clinical Oncology (ASCO) conference.
Lunit Unveils Enhanced AI-Powered CXR Software Update
May 28th 2025The Lunit Insight CXR4 update reportedly offers new features such as current-prior comparison of chest X-rays (CXRs), acute bone fracture detection and a 99.5 percent negative predictive value (NPV) for identifying normal CXRs.
New MRI Study Questions Use of Corticosteroid Injections for Knee OA
May 27th 2025Two years after intraarticular knee injections for knee osteoarthritis (OA), study participants who had corticosteroid knee injections had greater OA progression than control patients while the use of hyaluronic acid injections was associated with less OA progression.
